Analystreport

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) had its price target raised by analysts at Credit Suisse Group AG from $11.00 to $12.00. They now have a "neutral" rat

Ironwood Pharmaceuticals, Inc. - Class A  (IRWD) 
Last ironwood pharmaceuticals, inc. - class a earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.ironwoodpharma.com